Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart.

Kouris NA, Squirrell JM, Jung JP, Pehlke CA, Hacker T, Eliceiri KW, Ogle BM.

Regen Med. 2011 Sep;6(5):569-82. doi: 10.2217/rme.11.48.

2.

Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology.

Dai W, Hale SL, Kay GL, Jyrala AJ, Kloner RA.

Regen Med. 2009 May;4(3):387-95. doi: 10.2217/rme.09.2.

3.

Biomaterial strategies for alleviation of myocardial infarction.

Venugopal JR, Prabhakaran MP, Mukherjee S, Ravichandran R, Dan K, Ramakrishna S.

J R Soc Interface. 2012 Jan 7;9(66):1-19. doi: 10.1098/rsif.2011.0301. Epub 2011 Sep 7. Review.

4.

Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.

Huang J, Zhang Z, Guo J, Ni A, Deb A, Zhang L, Mirotsou M, Pratt RE, Dzau VJ.

Circ Res. 2010 Jun 11;106(11):1753-62. doi: 10.1161/CIRCRESAHA.109.196030. Epub 2010 Apr 8.

5.

Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart.

Assis AC, Carvalho JL, Jacoby BA, Ferreira RL, Castanheira P, Diniz SO, Cardoso VN, Goes AM, Ferreira AJ.

Cell Transplant. 2010;19(2):219-30. doi: 10.3727/096368909X479677. Epub 2009 Nov 10.

PMID:
19906330
6.

A plant-derived remedy for repair of infarcted heart.

Cheng L, Chen H, Yao X, Qi G, Liu H, Lee K, Lee K, Zhang J, Chen S, Lin X, Zhao W, Li J, Li M.

PLoS One. 2009;4(2):e4461. doi: 10.1371/journal.pone.0004461. Epub 2009 Feb 14.

7.

Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells.

Song H, Chang W, Lim S, Seo HS, Shim CY, Park S, Yoo KJ, Kim BS, Min BH, Lee H, Jang Y, Chung N, Hwang KC.

Stem Cells. 2007 Jun;25(6):1431-8. Epub 2007 Mar 8.

8.

Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.

Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, Chen B, Zhou F, Zhu TB, Wang LS, Xu ZQ, Zhang FM, Cao KJ, Ma WZ.

Gene Ther. 2006 Nov;13(22):1564-8. Epub 2006 Jun 29.

PMID:
16810195
9.

The reduction in immunogenicity of neurotrophin overexpressing stem cells after intra-striatal transplantation by encapsulation in an in situ gelling collagen hydrogel.

Hoban DB, Newland B, Moloney TC, Howard L, Pandit A, Dowd E.

Biomaterials. 2013 Dec;34(37):9420-9. doi: 10.1016/j.biomaterials.2013.08.073. Epub 2013 Sep 17.

PMID:
24054846
10.

Adipose-derived stem cell delivery into collagen gels using chitosan microspheres.

Natesan S, Baer DG, Walters TJ, Babu M, Christy RJ.

Tissue Eng Part A. 2010 Apr;16(4):1369-84. doi: 10.1089/ten.TEA.2009.0404.

11.

Localization of mesenchymal stem cells grafted with a hyaluronan-based scaffold in the infarcted heart.

Fiumana E, Pasquinelli G, Foroni L, Carboni M, Bonafé F, Orrico C, Nardo B, Tsivian M, Neri F, Arpesella G, Guarnieri C, Caldarera CM, Muscari C.

J Surg Res. 2013 Jan;179(1):e21-9. doi: 10.1016/j.jss.2012.01.028. Epub 2012 Mar 27.

PMID:
22475350
12.

Novel vascular endothelial growth factor gene delivery system-manipulated mesenchymal stem cells repair infarcted myocardium.

Zhu K, Lai H, Guo C, Xu D, Wang C.

Exp Biol Med (Maywood). 2012 Jun;237(6):678-87. doi: 10.1258/ebm.2012.011430. Epub 2012 Jun 22.

PMID:
22728704
13.
14.

Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium.

Song SW, Chang W, Song BW, Song H, Lim S, Kim HJ, Cha MJ, Choi E, Im SH, Chang BC, Chung N, Jang Y, Hwang KC.

Stem Cells. 2009 Jun;27(6):1358-65. doi: 10.1002/stem.47.

15.

Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.

Mias C, Lairez O, Trouche E, Roncalli J, Calise D, Seguelas MH, Ordener C, Piercecchi-Marti MD, Auge N, Salvayre AN, Bourin P, Parini A, Cussac D.

Stem Cells. 2009 Nov;27(11):2734-43. doi: 10.1002/stem.169.

16.

Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis.

Rosen AB, Kelly DJ, Schuldt AJ, Lu J, Potapova IA, Doronin SV, Robichaud KJ, Robinson RB, Rosen MR, Brink PR, Gaudette GR, Cohen IS.

Stem Cells. 2007 Aug;25(8):2128-38. Epub 2007 May 10.

17.

Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration.

Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K, Hotta T.

Spine (Phila Pa 1976). 2005 Nov 1;30(21):2379-87.

PMID:
16261113
18.

Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells.

Tan G, Shim W, Gu Y, Qian L, Chung YY, Lim SY, Yong P, Sim E, Wong P.

Differentiation. 2010 Apr-Jun;79(4-5):260-71. doi: 10.1016/j.diff.2010.02.005. Epub 2010 Mar 21.

PMID:
20307924
19.

Biomaterials to enhance stem cell function in the heart.

Segers VF, Lee RT.

Circ Res. 2011 Sep 30;109(8):910-22. doi: 10.1161/CIRCRESAHA.111.249052. Review.

20.

AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.

Yu YS, Shen ZY, Ye WX, Huang HY, Hua F, Chen YH, Chen K, Lao WJ, Tao L.

Chin Med J (Engl). 2010 Jul;123(13):1702-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk